Compare Cadila Healthcare with Aventis Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CADILA HEALTHCARE vs SANOFI INDIA - Comparison Results

CADILA HEALTHCARE     Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

SANOFI INDIA 
   Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CADILA HEALTHCARE SANOFI INDIA CADILA HEALTHCARE/
SANOFI INDIA
 
P/E (TTM) x 14.4 34.5 41.7% View Chart
P/BV x 2.8 6.1 46.4% View Chart
Dividend Yield % 1.5 1.4 101.2%  

Financials

 CADILA HEALTHCARE   SANOFI INDIA
EQUITY SHARE DATA
    CADILA HEALTHCARE
Mar-18
SANOFI INDIA
Dec-18
CADILA HEALTHCARE/
SANOFI INDIA
5-Yr Chart
Click to enlarge
High Rs5586,840 8.2%   
Low Rs3624,630 7.8%   
Sales per share (Unadj.) Rs116.31,203.1 9.7%  
Earnings per share (Unadj.) Rs17.9165.3 10.8%  
Cash flow per share (Unadj.) Rs23.1209.9 11.0%  
Dividends per share (Unadj.) Rs3.5084.00 4.2%  
Dividend yield (eoy) %0.81.5 52.0%  
Book value per share (Unadj.) Rs85.4963.6 8.9%  
Shares outstanding (eoy) m1,023.7423.03 4,445.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.04.8 82.9%   
Avg P/E ratio x25.734.7 74.1%  
P/CF ratio (eoy) x19.927.3 72.7%  
Price / Book Value ratio x5.46.0 90.4%  
Dividend payout %19.650.8 38.5%   
Avg Mkt Cap Rs m470,664132,078 356.4%   
No. of employees `00011.83.3 358.0%   
Total wages/salary Rs m18,5454,068 455.9%   
Avg. sales/employee Rs Th10,072.78,393.8 120.0%   
Avg. wages/employee Rs Th1,569.11,232.4 127.3%   
Avg. net profit/employee Rs Th1,547.71,153.0 134.2%   
INCOME DATA
Net Sales Rs m119,04927,708 429.7%  
Other income Rs m1,132897 126.2%   
Total revenues Rs m120,18128,605 420.1%   
Gross profit Rs m28,4756,235 456.7%  
Depreciation Rs m5,3881,027 524.6%   
Interest Rs m9117 13,014.3%   
Profit before tax Rs m23,3086,098 382.2%   
Minority Interest Rs m6280-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5,6442,292 246.2%   
Profit after tax Rs m18,2923,806 480.6%  
Gross profit margin %23.922.5 106.3%  
Effective tax rate %24.237.6 64.4%   
Net profit margin %15.413.7 111.9%  
BALANCE SHEET DATA
Current assets Rs m82,00515,922 515.0%   
Current liabilities Rs m60,7206,235 973.9%   
Net working cap to sales %17.935.0 51.1%  
Current ratio x1.42.6 52.9%  
Inventory Days Days7364 114.9%  
Debtors Days Days9821 471.1%  
Net fixed assets Rs m83,7037,539 1,110.3%   
Share capital Rs m1,024230 445.2%   
"Free" reserves Rs m86,42121,962 393.5%   
Net worth Rs m87,44522,192 394.0%   
Long term debt Rs m25,5510-   
Total assets Rs m180,65329,839 605.4%  
Interest coverage x26.6872.1 3.0%   
Debt to equity ratio x0.30-  
Sales to assets ratio x0.70.9 71.0%   
Return on assets %10.612.8 83.2%  
Return on equity %20.917.2 122.0%  
Return on capital %22.027.5 79.9%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m42,6837,587 562.6%   
Fx outflow Rs m11,2427,145 157.3%   
Net fx Rs m31,441442 7,113.3%   
CASH FLOW
From Operations Rs m9,1933,739 245.9%  
From Investments Rs m-9,737-731 1,332.0%  
From Financial Activity Rs m515-1,972 -26.1%  
Net Cashflow Rs m-291,036 -2.8%  

Share Holding

Indian Promoters % 74.8 0.0 -  
Foreign collaborators % 0.0 60.4 -  
Indian inst/Mut Fund % 8.3 14.4 57.6%  
FIIs % 5.9 14.6 40.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 11.0 10.5 104.8%  
Shareholders   44,069 15,184 290.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CADILA HEALTHCARE With:   DR. DATSONS LABS  STRIDES PHARMA SCIENCE  TTK HEALTHCARE  JUBILANT LIFE SCIENCES  BIOCON   

Compare CADILA HEALTHCARE With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Slips Over 300 Points; Axis Bank & Tech Mahindra Top Losers(12:30 pm)

Share markets in India have extended early losses and are presently trading deep in the red. Barring consumer durables sector, all sectoral indices are trading in red with stocks in the telecom sector.

Related Views on News

CADILA HEALTHCARE Announces Quarterly Results (1QFY20); Net Profit Down 28.9% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, CADILA HEALTHCARE has posted a net profit of Rs 3 bn (down 28.9% YoY). Sales on the other hand came in at Rs 35 bn (up 20.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

SANOFI INDIA Announces Quarterly Results (1QFY20); Net Profit Down 2.2% (Quarterly Result Update)

Jul 31, 2019 | Updated on Jul 31, 2019

For the quarter ended June 2019, SANOFI INDIA has posted a net profit of Rs 974 m (down 2.2% YoY). Sales on the other hand came in at Rs 7 bn (up 9.4% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (4QFY19); Net Profit Down 21.0% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (down 21.0% YoY). Sales on the other hand came in at Rs 37 bn (up 14.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

SANOFI INDIA Announces Quarterly Results (4QFY19); Net Profit Up 12.6% (Quarterly Result Update)

May 8, 2019 | Updated on May 8, 2019

For the quarter ended March 2019, SANOFI INDIA has posted a net profit of Rs 929 m (up 12.6% YoY). Sales on the other hand came in at Rs 7 bn (up 16.1% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

SANOFI INDIA 2017-18 Annual Report Analysis (Annual Result Update)

Apr 16, 2019 | Updated on Apr 16, 2019

Here's an analysis of the annual report of SANOFI INDIA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of SANOFI INDIA. Also includes updates on the valuation of SANOFI INDIA.

More Views on News

Most Popular

Buying these Eight Stocks is Like Owning Your Own Business(Profit Hunter)

Sep 5, 2019

Everyone dreams of owning a business. Here is your chance.

7 Stocks to Buy in the Market Today(The 5 Minute Wrapup)

Sep 5, 2019

The stock market had a four-year bull run starting September 2013. Are we seeing a similar pattern now?

Don't Buy Lakshmi Vilas Bank...Buy this Private Sector Bank with 74% Upside(The 5 Minute Wrapup)

Sep 4, 2019

Lakshmi Vilas Bank is in a vicious cycle. The stock is already down 57% in 2019. Despite this, the retail investors increased their holding.

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

A Recession Proof Stock You Can Bet On(Profit Hunter)

Sep 10, 2019

Usually, the typical horizon period for my smallcap recommendations is 3 to 5 years. But if you ask me, this could be one business that you could own and pass on to future generations.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

CADILA HEALTHCARE SHARE PRICE


Sep 17, 2019 02:23 PM

TRACK CADILA HEALTHCARE

  • Track your investment in CADILA HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CADILA HEALTHCARE

CADILA HEALTHCARE 8-QTR ANALYSIS

COMPARE CADILA HEALTHCARE WITH

MARKET STATS